Peg Powder, For Solution
NDC 50090-8020
View dosage, usage, ingredients, routes, and UNII mappings.
Product Information
Peg (polyethylene glycol 3350, sodium sulfate anhydrous, sodium bicarbonate, sodium chloride, potassium chloride) is a NDA AUTHORIZED GENERIC-approved product labeled by A-s Medication Solutions. This medication is typically used as a increased large intestinal motility [pe]. It is supplied as a powder, for solution for oral administration. This product entry covers the primary NDC 50090-8020 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
NDC Product Code:
50090-8020
Proprietary Name:
Peg 3350 And Electrolytes
Non-Proprietary Name: [1]
Polyethylene Glycol 3350, Sodium Sulfate Anhydrous, Sodium Bicarbonate, Sodium Chloride, Potassium Chloride
Substance Name: [2]
Polyethylene Glycol 3350; Sodium Sulfate Anhydrous; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride
NDC Directory Status:
Human Prescription Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Code Navigator:
Clinical Specifications
Dosage Form:
Powder, For Solution
- An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution.
Administration Route(s): [4]
Oral - Administration to or by way of the mouth.
Labeler & Regulatory Data
Labeler Name: [5]
Labeler Code:
50090
Product Label ID:
FDA Application Number: [6]
NDA019011
Marketing Category: [8]
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Marketing Timeline
Start Marketing Date: [9]
07-01-2009
Listing Expiration Date: [11]
12-31-2027
Exclude Flag: [12]
N
Code Structure Chart
Product Details
What is NDC 50090-8020?
The NDC code 50090-8020 is assigned by the FDA to the product Peg 3350 And Electrolytes. It is commonly known by its generic name, polyethylene glycol 3350, sodium sulfate anhydrous, sodium bicarbonate, sodium chloride, potassium chloride. This pharmaceutical product is labeled by A-s Medication Solutions and is currently categorized as listed product. The medication is a powder, for solution administered via oral route. In terms of distribution, this product is available in a single package configuration. The associated package NDC(s) include: 50090-8020-0. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.
What are the uses of this product?
PEG-3350 and Electrolytes for Oral Solution is indicated for bowel cleansing prior to colonoscopy and barium enema X-ray examination in adults.
What are Active Ingredients of this product?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
- POLYETHYLENE GLYCOL 3350 236 g/4L
- SODIUM SULFATE ANHYDROUS 2.97 g/4L
- SODIUM BICARBONATE 6.74 g/4L - A white, crystalline powder that is commonly used as a pH buffering agent, an electrolyte replenisher, systemic alkalizer and in topical cleansing solutions.
- SODIUM CHLORIDE 5.86 g/4L - A ubiquitous sodium salt that is commonly used to season food.
- POTASSIUM CHLORIDE 22.74 g/4L - A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)
- POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P) (Active Moiety)
- SODIUM SULFATE ANHYDROUS (UNII: 36KCS0R750)
- SODIUM CATION (UNII: LYR4M0NH37) (Active Moiety)
- SULFATE ION (UNII: 7IS9N8KPMG) (Active Moiety)
- SODIUM BICARBONATE (UNII: 8MDF5V39QO)
- BICARBONATE ION (UNII: HN1ZRA3Q20) (Active Moiety)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- CHLORIDE ION (UNII: Q32ZN48698) (Active Moiety)
- POTASSIUM CHLORIDE (UNII: 660YQ98I10)
- POTASSIUM CATION (UNII: 295O53K152) (Active Moiety)
Which are the Pharmacologic Classes of this product?
A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
* Please review the full disclaimer at the bottom of this page.
Product & Regulatory Definitions
What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
What is the Substance Name? An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
What are the Administration Routes? The translation of the route code submitted by the firm, indicating route of administration.
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".